Prevalence and factors associated with alcohol and drug-related disorders in prison: a French national study by Lukasiewicz, Michael et al.
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
Substance Abuse Treatment, 
Prevention, and Policy
Open Access Short Report
Prevalence and factors associated with alcohol and drug-related 
disorders in prison: a French national study
Michael Lukasiewicz*†1,2, Bruno Falissard†1, Laurent Michel2, Xavier Neveu1, 
Michel Reynaud2 and Isabelle Gasquet†1,3
Address: 1INSERM, U669, Paris, F-75014 France ; Univ Paris-sud 11, Le Kremlin Bicêtre, F-94000 France; Univ Paris 5, Paris, F-75015 France; AP-
HP, Villejuif, F-94804, France, 2Centre de Recherche et de Traitement des Addictions., Assistance Publique-Hopitaux de Paris, Hôpital Paul 
Brousse, 14 avenue PV Couturier, Villejuif 94804, France and 3Direction de la politique Médicale, Assistance Publique – Hôpitaux de Paris, 3 
avenue Victoria, 75184 Paris cedex 4, France
Email: Michael Lukasiewicz* - michael.lukasiewicz@gmail.com; Bruno Falissard - falissard_b@wanadoo.fr; 
Laurent Michel - laurentmichel@gmail.com; Xavier Neveu - xavier.neveu@hotmail.fr; Michel Reynaud - michel.reynaud@pbr.ap-hp.fr; 
Isabelle Gasquet - isabelle.gasquet@sap.aphp.fr
* Corresponding author    †Equal contributors
Abstract
Background: Most studies measuring substance-use disorders in prisons focus on incoming or on
remand prisoners and are generally restricted to drugs. However, there is evidence that substance
use initiation or continuation occurs in prison, and that alcohol use is common. The aim of this
study is 1) to assess prevalence of both drug and alcohol abuse and dependence (DAD/AAD) in a
national randomised cohort of French prisoners, short or long-term sentence 2) to assess the risk
factors associated with DAD/AAD in prison. a stratified random strategy was used to select 1) 23
prisons among the different types of prison 2) 998 prisoners. Diagnoses were assessed according
to a standardized procedure, each prisoner being assessed by two psychiatrists, one junior, using a
structured interview (MINI 5 plus), and one senior, completing the procedure with an open clinical
interview. At the end of the interview the clinicians met and agreed on a list of diagnoses.
Cloninger's Temperament and Character Inventory (TCI) was also used.
Results: More than a third of prisoners presented either AAD or DAD in the last 12 months.
Cannabis was the most frequent drug and just under a fifth of prisoners had AAD. AAD and DAD
were clearly different for the following: socio-demographic variables, childhood history,
imprisonment characteristics, psychiatric comorbidity and Cloninger's TCI. Profiles of AAD in
prison are similar to type II alcoholism.
Conclusion: Regular screening of AAD/DAD in prison, and specific treatment programmes taking
into account differences between prisoners with an AAD and prisoners with a DAD should be a
public health priority in prison
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Background
Drug users are over-represented in prisons in Europe. Nev-
ertheless, data on patterns of drug use among prisoners
are rare and difficult to interpret: Indeed, a large part
comes from non-controlled or local studies, using differ-
ent data collection methods. Furthermore, the fear of con-
fidentiality breaches may bias prisoners' answers. Finally,
systematic screening is unusual in prison setting, concern-
ing less than 60% of incoming prisoners in France [1-4].
Lifetime prevalences across Europe for regular drug use
prior to imprisonment vary widely, from 8% to 73% [5].
In France, in 2003, just over 30% reported alcohol abuse
and a third regular drug use in the past 12 months [6].
Estimates of abuse/dependence prevalence in prisons
Few studies have focused on standardized diagnoses of
alcohol or drug abuse/dependence (AAD and DAD)
among prisoners, and most were limited to incoming or
remanded prisoners: estimates ranging from 25% to 74%
for DAD and from 21% to 50% for AAD have been
reported [7-13]. In contrast, with the notable exception of
a national British study [14-17], few national studies have
targeted the general prisoner population. However, sub-
stance misuse while in prison is not uncommon, whether
ongoing substance misuse or first consumption: estimates
ranges from 22% to 86%, cannabis being the most fre-
quently reported illicit drug used (8–60%), and injecting
being reported by 0–28% of inmates [5,18]. A British sur-
vey found that 60% of heroin users reported use in prison
and more than 25% initiated use in prison [17]. AAD/
DAD prevalence among all prisoners, not solely incom-
ing/remanded prisoners, is still largely unknown in
France.
Studies on factors associated with substance use in prison
A number of factors have been associated with AAD/DAD
in the general population. Few studies have explored
these factors in DAD prisoners and most were again lim-
ited to incoming/remanded prisoners. Among the signifi-
cant factors are: age, ethnicity [17], childhood conduct
disorders, childhood abuse, school difficulties [17,19-22],
additional substance-related disorder, previous psychiat-
ric treatment, co-morbid psychiatric diagnosis, psychosis,
mood disorder, antisocial personality, self-harm, suicide
risk, history of serious illness or injury [16,17,21-23],
fewer qualifications, unemployment, housing difficulties
[21] and the length of time spent in prison [17]. AAD in
prison has been generally ignored, yet alcohol has been
widely related to violent behaviour and criminality. Alco-
hol consumption is forbidden in prison but alcohol traf-
ficking and "home brew" production have been reported
inside prisons. No studies have differentiated the profiles
of AAD/DAD. Yet better knowledge of these differences
could allow better screening as well as tailoring of specific
prevention/treatment programmes.
The aim of this paper is 1/to assess AAD and DAD preva-
lence in a national randomized cross-sectional survey
concerning the adult prisoner population, not restricted
to incoming or remanded prisoners alone, assuming that
a substantial proportion of prisoners continue or initiate




The demographic profile of the population is presented in
table 1. Four prisoners out of five were under fifty (mean
age in years: 39 ± 13), and just above 80% had no, or very
low educational achievement. Childhood history of
adverse events was frequent and one quarter of the prison-
ers had had a contact with a children's judge before the
age of 18 (Table 1). 46.6% (n = 465) had been already
incarcerated and the most frequent crimes committed
were against persons (52.7%) (Table 2). The mean time
already spent in prison was 16.5 (SD = 22.3) months.
The most frequent psychiatric diagnoses were current and
lifetime mood disorders and current anxiety disorders,
with nearly half the prisoners having one of these diag-
noses. More than a quarter of the prisoners had attempted
suicide and just under fifty percent had had a contact with
a psychiatric department (Table 3).
Prevalence of drug and alcohol abuse/dependence in 
prison (table 1)
35.2% of prisoners presented either AAD or DAD in the
last 12 months. 18.4% had presented AAD and 27.9%
DAD in the last 12 months. 11.2% (N = 111) had both
diagnoses in the previous 12 months.
Cannabis was the most frequently used drug in the previ-
ous 12 months (26.7%), others drug use being marginal
(2.7% for opiate to 5.4% for cocaine/crack).
Socio-demographics and childhood history of prisoners 
with AAD/DAD (table 1)
Sociodemographic factors associated with DAD were very
different from those associated with AAD (table 1).
Married prisoners were less likely diagnosed DAD than
non-married (OR = 0.4), as well as the older prisoners
compared to the younger (OR = 0.5), and finally those
separated early in childhood from one parent were at
higher risk (OR = 1.6).
Compared to non-users, prisoners with an AAD had a
lower level of education (significant for low-grade techni-
cal diplomas (OR = 2.6)).Substance Abuse Treatment, Prevention, and Policy 2007, 2:1 http://www.substanceabusepolicy.com/content/2/1/1
Page 3 of 10
(page number not for citation purposes)
Imprisonment factors associated with alcohol and drug 
abuse/dependence in prison (table 2)
DAD and AAD prisoners were also different for this set of
variables (table 2).
Prisoners with DAD were over-represented in the overseas
département (OR = 5.7), and among re-offenders (OR =
2.6). They had more frequently committed crimes against
persons (OR = 1.9, ref: crimes against property), and were
more often subjected to disciplinary measures (OR = 1.7).
Prisoners with AAD were over-represented in maisons
d'arrêt (short term) and under-represented in prisons cent-
rales (long term), less likely to be sentenced to more than
five years (OR = 0.26) and had more frequently commit-
ted crime against property (OR = 2.7).
Psychiatric disorders and temperament of prisoners with 
drug or alcohol abuse/dependence (table 3)
AAD and DAD were reciprocally associated (OR > 3) but
their psychiatric and TCI profiles were clearly different
(table 3).
DAD was not associated with another psychiatric disorder
but was more frequent in case of marked novelty-seeking
(OR = 1.2) and low self-directedness (OR= 2.1)
Table 1: comparison of socio-demographic status and child history variables for prisoners with a drug abuse/dependence (N = 278) or 
an alcohol abuse/dependence (N = 174)
Total Drug abuse and dependence (last 12 
months)
Alcohol abuse and dependence (last 
12 months)
N = 998 Yes (278) No (720) Yes (174) No (824)
%(N) % % Odd ratio 
[IC95]1
% % Odd ratio 
[IC95]1
Socio-demographic status
Gender Female 9.9(99) 6.5 11.2 7.1 10.6
Class of age (qualitative ordinate)
18–29 years (ref) 29.0(289) 48.2 21.5 1 44.0 25.5
30–39 years 27.3(273) 23.3 38.1 0.5(0.4–0.6)‡ 31.0 26.6
40–49 years 23.6(236) 28.3 11.4 0.3(0.2–0.4)‡ 17.9 24.9
50–59 years 12.1(121) 2.2 16.0 0.0(0.0–0.1)‡ 6.0 13.5
60 years and more 7.9(79) 0.0 11.0 0.0(0.0–0.1)‡ 1.1 9.5
Education High school diploma (ref) 11.6(116) 7.9 13.1 4.9 13.1 1
No education 45.7(455) 50.4 43.7 50.6 44.5 2.1(0.97–4.7)
GCSE 35.3(352) 39.2 33.7 41.8 33.8 2.6(1.2–5.7)*
University 7.3(75) 2.5 9.5 2.7 8.6 0.9(0.3–3.2)
Marital status Single (ref) 41.2(411) 62.2 33.5 1 52.2 38.7
Married 36.0(358) 25.2 40.0 0.4(0.3–0.6)‡ 29.3 37.4
Separated 19.7(196) 11.9 23.1 0.7(0.4–1.2) 17.4 20.5
Widow 3.0(30) 0.7 3.9 0.6(0.1–3.9) 1.1 3.4
Employment for at least two year (yes) 63.2(574) 59.0 34.2 44.0 62.3
Child history§
Judge in childhood 26.9269) 45.7 19.7 42.9 23.3
Separation from one parent
> 6 month
43.2(431) 57.5 37.6 1.6(1.1–2.3)* 49.5 41.8
Family with a history of
imprisonment
30.2(301) 41.7 25.7 40.2 27.9
Placement 21.9(219) 33.8 17.4 30.4 20.0
Death of a family member
in childhood
35.1(350) 40.6 32.9 38.0 34.4
Ill-Treatment 29.8(297) 40.3 25.7 40.8 27.3
Previous history of trauma
(other than ill-Treatment)
24.5(245) 34.2 20.8 1.9(1.3–2.9)** 29.9 23.3
1The odd ratio presented were obtained after a logistic regression using a stepwise selection process (α = 0.05), adjusted on DSM IV psychiatric 
disorders, psychiatric history, temperaments, socio-demographic status, childhood history And imprisonment characteristics.
§"No" is the reference for all these variables
*p < 0.05 ** p < 0.01 † p < 0.001 ‡ p < 0.0001Substance Abuse Treatment, Prevention, and Policy 2007, 2:1 http://www.substanceabusepolicy.com/content/2/1/1
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AAD was significantly associated with current mood dis-
order (OR = 2.0), antisocial personality (OR = 2.3) and
low reward dependence
Discussion
The data from this random national sample of 998 French
adult prisoners in 23 prisons, including short and long
term sentences, highlights the following:
1. More than a third of prisoners had either an AAD or
DAD in the previous 12 months. Cannabis was the most
frequent drug used.
2. While drug use in prison is a well-known problem,
alcohol use also seems frequent, with nearly a fifth of pris-
oners presenting AAD.
3. Finally, while no direct comparisons were performed,
risk factors associated to ADD and risk factors associated
to DAD were distributed differently. These two groups
also differed from other prisoners regarding some of these
variables
Strengths and limits of the study
One strong point of this national random study is that all
types of prisoners were assessed, and not only prisoners
on remand or incoming prisoners, and that it involved the
different types of French prison settings (which vary con-
siderably in terms of security, length of sentence, etc.). We
can thus assume that our sample is representative of
French prisoners, and that it can give an overview of drug
use during imprisonment. It is however possible that pris-
oners incarcerated for more than 12 months, compared to
incoming prisoners, under-reported their past substance
use, as it necessarily took place in prison, fearing sanctions
in case of breach of confidentiality. However, the high
prevalences found are not in favour of under-reporting.
A report bias may have occurred for prisoners incarcerated
less than 6 months, as their substance use may have been
interrupted in jail. The link with "maison d'arret" (where
most of the sentences are short term) should then be
taken cautiously.
Another point is that no objective measures (urine/blood
tests) of substance use were performed and that the diag-
noses were based only on a clinical assessment. This is a
general problem encountered in substance-use disorder
(SUD) prevalence studies, but this tendency to under-
report SUD may be greater in prison. Indeed, prisoners
may fear disciplinary measures or reduced access to their
supplier if they report substance use. Moreover, most of
the standardized diagnosis instruments are not validated
in prison, where antisocial personality diagnosis is fre-
quent, and where prisoners may falsify report on their
psychiatric status to gain benefits from "patient" status.
Table 2: comparison of imprisonment characteristics for prisoners with a drug abuse/dependence (N = 278) or an alcohol abuse/
dependence (N = 174)
Total Drug abuse and dependence (last 12 
months)
Alcohol abuse and dependence (last 12 months)
N = 998 Yes (278) No (720) Yes (174) No (824)
%(N) % (N) Odd ratio 
[IC95%]1
(N) (N) Odd ratio 
[IC95%]1
Type of prison "Center de detention" (ref) 25.0(249) 16.2 28.3 1 14.1 27.4 1
"Arrest house" 55.0(549) 62.6 52.1 1.5(0.9–2.5) 72.3 51.1 2.0(1.2–3.4)**
"Central house" 10.0(100) 4.0 12.4 0.7(0.3–1.5) 0.6 12.2 0.1(0.02–0.97)*
"Overseas department" 10.0(100) 17.2 7.2 5.7(2.9–11.3)‡ 13.0 9.3 1.7(0.8–3.4)
Previous history of imprisonment (ref: no) 46.6(465) 66.5 38.9 2.6(1.8–3.9)‡ 59.2 43.7
Length of time spent in 
prison
<= 6 months (ref) 33.3(332) 47.1 27.9 52.7 28.9
Six months-one year 25.7(257) 24.9 26.1 25.0 25.9
One year – two years 19.9(199) 16.5 21.2 14.7 21.1
Two years – five years 16.8(168) 10.8 19.2 7.0 19.1
Five years and more 4.2(42) 0.7 5.6 0.6 5.0
Length of sentence Less than six month (ref) 4.0(40) 7.2 2.8 8.1 3.1 1
Between 6 months to one year 11.7(111) 21.9 7.8 23.9 9.0 0.9(0.4–2.0)
Between one to five years 37.1(370) 47.2 33.2 49.5 34.2 0.7(0.4–1.7)
More than five years 47.2(471) 23.7 56.2 18.6 53.7 0.3(0.1–0.6)‡
Type of crime Crime against people (ref) 52.7(526) 33.1 60.3 1 45.7 54.3 1
Crime against property 37.9(378) 54.0 31.6 2.7(1.8–4.0)‡ 45.1 36.2 0.5(0.4–0.9)†
Both 9.4(94) 12.9 8.1 1.7(0.9–3.1) 9.2 9.5 0.7(0.3–1.4)
1The odd ratio presented were obtained after a logistic regression using a stepwise selection process (α = 0.05), adjusted on DSM IV psychiatric 
disorders, psychiatric history, temperaments, socio-demographic status, childhood history and imprisonment characteristics.
*p < 0.05 ** p < 0.01 †p < 0.001 ‡p < 0.0001Substance Abuse Treatment, Prevention, and Policy 2007, 2:1 http://www.substanceabusepolicy.com/content/2/1/1
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We limited the effect of the setting by 1) ensuring strict
confidentiality of the interview 2) using a diagnosis
assessment procedure that improved inter-rater agree-
ment 3) adjusting results on the presence of antisocial per-
sonality. It should be noted that blood/urine tests alone
may not be more valid than a good clinical assessment,
since for drugs with a short lifetime, false negative results
could be frequent and repeated measures too costly.
Prevalence of alcohol and drug abuse or dependence in 
prison
The first point to be made is that psychiatric disorder prev-
alence rates found in this study are higher than most of
those already published. One of the main discrepancies
concerns current and lifetime mood disorders (affecting
around half the prisoners) while a systematic review of
surveys in general prison populations in western countries
shows prevalences not exceeding 10% [24]. Several non-
exclusive explanations may be proposed for these differ-
ences: first, these studies used different instruments; sec-
ond, none was conducted in France (in favour of this, a
paper published in 2004 [25] reports that prevalence of
depression was as high as 27.4% in French prisons); third,
certain depressive symptoms are over-represented because
of the prison context (e.g. sleeping disorders).
The second point, often neglected in studies, is that AAD
prevalence observed here also very high. This could be, as
Table 3: comparison of diagnosis and psychopathology variables for prisoners with a drug abuse/dependence (N = 278) or an alcohol 
abuse/dependence (N = 174)
Total Drug abuse and dependence (last 12 
months)-
Alcohol abuse and dependence (last 12 months)
N = 998 Yes (278) No (720) Yes (174) No(824)
%(N) % % Odd ratio 
[IC95%]1
% % Odd ratio [IC95%]1
DSMIV 
diagnosis
Mood disorder (LT) 55.6(555) 67.6 51.0 71.2 52.1
Mood disorder(Ct) 45.6(455) 54.3 42.2 61.4 42.0 2.0(1.4–3.0)†
Anxiety disorder(LT) 10.5(105) 13.3 9.4 14.6 9.5
Anxiety disorder(C) 54.5(544) 61.5 51.8 58.7 53.5
Psychotic disorder (LT) 24.7(247) 25.2 24.6 24.4 24.8
Psychotic disorder (C) 22.7(227) 22.3 22.9 22.8 22.7
Antisocial personality 31.5(315) 54.3 22.8 55.4 26.1 2.3(1.5–3.4)‡
Alcohol abuse and
dependence (12 m)
18.4(184) 39.9 10.1 3.9(2.5–5.9)‡ - --
Drug abuse and dependence
(12 m)
27.8(278) - - - 60.3 20.5 3.5(2.3–5.3)‡
Psychiatric 
history
Suicidal risk 40.5(404) 46.7 38.0 50.0 38.3
History of suicide attempt 28.7(287) 34.2 26.7 39.7 26.3
Psychiatric hospitalisation 16.2(162) 22.3 13.9 27.2 13.7
Psychiatric ambulatory care 36.7(366) 49.3 31.1 53.3 32.9
Temperament and character Inventory
Novelty seeking low 39.7(396) 24.4 45.6 1 21.7 43.7
moderate 22.4(224) 20.1 23.3 1.3(1.0–1.6)* 22.8 22.4
high 37.9(378) 55.5 31.1 1.6(1.3–2.0)* 55.5 33.9
Harm avoidance low 44.5(444) 47.1 43.5 41.3 45.2
moderate 25.1(251) 19.1 27.5 22.3 25.8
high 30.4(303) 33.8 29.0 36.4 29.0
Reward dependence low 25.4(254) 27.3 24.7 26.6 25.2 1
moderate 31.7(316) 25.2 34.2 34.3 31.1 0.7(0.6–0.9)*
high 42.9(428) 47.5 41.1 39.1 43.7 0.6(0.2–0.8)*
Low persistence 20.0(200) 27.0 17.3 29.3 17.9
Low cooperativeness 18.0(180) 25.5 15.1 25.5 16.3
Low self-directedness 29.8(298) 47.8 22.9 2.1(1.4–3.1)† 44.6 26.5
Low self-transcendence 37.6(375) 51.1 32.4 47.3 35.4
LT : lifetime C: current
1 The odd ratio presented were obtained after a logistic regression using a stepwise selection process (α = 0.05), adjusted on DSM IV psychiatric 
disorders, psychiatric history, temperaments, socio-demographic status, childhood history and imprisonment characteristics.
*p < 0.05 ** p < 0.01 †p < 0.001 ‡p < 0.0001Substance Abuse Treatment, Prevention, and Policy 2007, 2:1 http://www.substanceabusepolicy.com/content/2/1/1
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in Finland and Denmark, the effect of national culture,
but an alternative explanation is that only illicit drugs are
generally investigated.
Thirdly, cannabis was the most frequent drug used, con-
cerning a little over one in four prisoners, five times more
than opiate use. Previously, opiate dependence has been
reported as the most frequent drug disorder in prison [9].
This new trend reflects current French general population
use, where cannabis is widely used and where opiate use
and its crime-related consequences have decreased with
the introduction of maintenance treatment [5]. However,
cannabis has also been trivialized and tolerated by prison
authorities compared to other drugs which could thus
have been under-reported.
Finally, certain socio-demographic, psychopathological
and imprisonment characteristics clearly distinguish pris-
oners with DAD from prisoners with AAD. These two
groups also differed from other prisoners regarding some
of these variables.
Comparison with the British national study of substance 
misuse in prison
When compared with the aforementioned British
national study of substance misuse in prison [14-17], the
conclusions are quite similar. Indeed, a very high preva-
lence of substance misuse (42.5%) were drug dependent
and alcohol problem (close to 30% had a severe alcohol
problem according to the AUDIT). Another interesting
point is that cannabis is also the first drug reported in
both study with similar prevalence (around 60%). How-
ever, while other drugs are rarely reported in our study
(cocaine being the most frequent with 5.7% of prisoners
reporting use), other drugs were relatively frequently used
in British prisons (between 19.1% (for cocaine) to 32.6%
for stimulants). They may be different explanations which
are not mutually exclusive: a fear of confidentiality
breach, a higher general prevalence of cocaine and stimu-
lant use in Great Britain, a difference in the availability of
opiate maintenance treatment in the two countries, etc.
However, comparing this two study remains difficult as
the British study mainly assess SUD prior to prison sen-
tence while our assessment focus on the last 12 months
prevalence, aggregating both prior and during prison sen-
tence term use. Our dependent variable is quite different
too, as we it covers both abuse and dependence. However,
we can conclude that in both countries substance use dis-
order is overwhelmingly represented in prison compared
to the general population.
Comparison with the general population
When compared to the available national data on drug
use in the French general population, our data are une-
quivocal and show that addicts are overwhelmingly over-
represented in prisons: 2.8% of French male adult have a
regular use of cannabis (but 18% of 17–18 years old have
a problematic use), less than one percent have ever used
heroin and 0.6% used once cocaine in the last 12 months
among the 15–64 [26]. When compared to our variable
"first drug used" (which is not strictly correct, but give an
idea of the discrepancy), the ratio is close to 9 times higher
in prison for cocaine and cannabis.
Psychopathology: comorbid psychiatric disorders
Concerning psychiatric co-morbidity, only prisoners with
an AAD seem to have greater vulnerability, restricted to
current mood disorder, an already well-established associ-
ation in general population [27]. We did not find any rela-
tion between psychosis and drug use, as reported by
recent British studies [15], but these results were contra-
dictory in one study [16] depending on the type of drug
used. It is particularly true for cannabis, that was the most
frequent drug reported in our study and which has been
moderately but significantly linked to psychosis in differ-
ent studies in general population (for a review of this
question, see [28]). One explanation is that our group was
more heterogeneous, aggregating abuse and dependence
and thus probably less severely dependant than the group
studied in this British study. Other differences in assessing
the primary variable may explain this discrepancy
between the two studies (see above). Additionally, our
dependant variable, which covers a broad range of sub-
stance abuse problem, has the inconvenient that it may
hide some associations with psychiatric comorbidities or
temperaments, which could be restricted to the most
severely dependent individuals. However, associations
with these more severe groups have already been reported
in other studies and we provide an approach that empha-
sizes a broader public health approach, as not only
dependence but abuse has been associated to psychologi-
cal difficulties. Furthermore, the causal impact of canna-
bis may be difficult to highlight in prison, as prisoners
with or without addiction are submitted to other strong
influences potentially responsible for psychosis (sensory
isolation, aggressive environment, etc.) that can not be
objectively assessed and play the role of major confound-
ing factors.
Concerning anxious and mood disorders, while cannabis
has been involved in their development, the level of evi-
dence is not as important as for alcohol (for review see
[29]) and no consensus has been reached on this topic. It
is thus not surprising that no association is found for the
DAD group with these disorders.
Antisocial personality is classically expected to be more
frequent in DAD than in AAD, in line with the social rep-
resentation of deviance associated with drugs, alcohol
being legal while drugs are not. Contrary to our expecta-Substance Abuse Treatment, Prevention, and Policy 2007, 2:1 http://www.substanceabusepolicy.com/content/2/1/1
Page 7 of 10
(page number not for citation purposes)
tions, antisocial personality was significantly linked to
AAD but not to DAD. Two explanations can be proposed:
1) the relationship between antisocial personality and
DAD may be restricted to opiate users. Indeed, in our
study, cannabis superseded other drugs. Though cannabis
is not legal in France, it is not tagged with the same social
taboo as opiates. 2) Prisoners with an AAD seem to corre-
spond to a certain type of alcoholism, more prone to vio-
lent crime and less reward-sensitive, as we will detail
below.
Psychopathology: temperament and character
Some personality features have been commonly linked to
patients with SUD, the most salient variables being nov-
elty-seeking [30,31], impulsivity, and low harm avoid-
ance [32,33]. Few studies have tried to differentiate
between drug preferences (voir réf 36) and none have
studied this among jailed substance users. Results are con-
tradictory but some papers have reported clear differences:
healthy subjects with less attachment (a subdimension of
reward dependence) were more ethanol-preferring than
benzodiazepine preferring [34]; the constraint dimension
of Tellegen's Multiple test discriminated between AAD
and DAD [35]. A recent study using TCI reported that her-
oin users scored higher than subject with an alcohol-
related disorder on novelty-seeking and self-directedness,
and that exploratory excitability (a sub-dimension of nov-
elty-seeking) was the best variable to segregate these
groups. Subject with an alcohol dependence also had a
lower score than controls for certain subscales of reward
dependence [32]. Our study confirms some of these
results. However, novelty-seeking does not seem to be the
best discriminating factor, having a lower odds ratio com-
pared to low self-directness for DAD and low reward
dependence for AAD. These data may be useful to discrim-
inate these populations, but they are also interesting for
the tailoring and allocation of specific rehabilitation pro-
grams. Indeed, drug users have low self-directedness and
are therefore considered to be more impulsive, to have
riskier and more restricted modes of self-stimulation
(through novelty-seeking) but they are not prone to social
withdrawal. Conversely, prisoners with an AAD have a
low reward dependence temperament, which means they
are socially insensitive, irresolute and indifferent if alone,
which leads to social withdrawal.
Overall, jailed individuals with an AAD seem to differ
more from individuals with an AAD in the general popu-
lation (for whom novelty-seeking is the most sensitive fac-
tor [33,36]), than jailed drug users differ from drug users
in the general population. Indeed, prisoners with an AAD
have a low reward dependence temperament, are more
prone to crime against persons, have lower educational
status and a more antisocial personality. This is very close
to the description of Cloninger's alcoholic subtype II [37],
which is believed to be more genetically loaded and asso-
ciated with antisocial behaviours.
Childhood history
Prisoners with DAD had suffered more frequently from
childhood separation and trauma other than ill-treat-
ment. These associations have been widely reported in the
literature (for example [38,39]) but rarely demonstrated.
Separation from parents could lead to an insecure attach-
ment style which is associated with antisocial behaviours.
It should be noted that insecure attachment style was
more frequent among prisoners in a recent study [40]. For
alcohol-related disorders, in contrast, a recent longitudi-
nal study confirmed the lack of relationship between
childhood factors and adult drinking [41] while family
seems to be a more protective factor for DAD than for
AAD [42]. For trauma other than ill-treatment, subjectiv-
ity is known to be a major bias in traumatic stressor
report, in particular in SUD [43], and interpretation
should be cautious.
Imprisonment characteristics
Imprisonment characteristics were also different. One
unexpected finding is that in the overseas département
prison being imprisoned is strongly correlated with DAD.
This could be explained by laxer security and by the geo-
graphical situation of overseas départements, making
them a privileged channel for drug flow. Another point is
that re-offending is associated with drug abuse/depend-
ence. This was expected, as drug consumption is an illegal
act that can per se lead to prison. The fact that crime
against persons is more associated with alcoholism and
crime against property with drugs is not a surprise. One
direct explanation is that crime against persons is the con-
sequence of alcohol loss of inhibition for aggressive
behaviour, while prisoners with DAD commit crime to
obtain their drug.
Public health and policy implications
Money and human resources allocated to mental health
programmes in prison are very limited in most European
countries. Can these profiles distinguishing between
jailed AAD and DAD subjects be exploited to tailor more
specific prevention/treatment/rehabilitation programs?
According to our results, which need to be replicated, pro-
grammes focusing mainly on addiction could be applied
to prisoners with a drug-related disorder, while additional
psychiatric care or integrated programmes should be
favoured for prisoners with an alcohol-related disorder.
Prisoners with an AAD also seem to be in greater need of
education and social skills, while prisoners with a DAD
should be directed toward programmes stressing other
means of stimulation than novelty-seeking and focusing
low self-directedness (anger management program, prob-Substance Abuse Treatment, Prevention, and Policy 2007, 2:1 http://www.substanceabusepolicy.com/content/2/1/1
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lem-solving skills, etc.). However, compared to self-direct-
edness which is believed to be a learned trait that thus
may be improved by therapy both novelty-seeking and
reward-dependence are temperament-based, more geneti-
cally loaded and less sensitive to learning. Furthermore,
caution is required in translating these results into prac-
tice, as no longitudinal data has proven the efficiency of
preventive strategies based on personality screening,
which could moreover stigmatize extreme personalities.
Conclusion
This study shows the importance of regular screening of
all prisoners and not only incoming prisoners, if we want
to address the drug use/initiation problem in prison.
Finally, a crucial public health question is the high preva-
lence of SUD observed in prison, with cumulating evi-
dence in the literature of maintenance or initiation while
in prison: Are prisons the right places to direct these peo-
ple, many of whom have committed offences in relation
drug legislation? Consideration of these issues by addic-
tion specialists, as well as judiciary and prison specialists,




In the year 2002, the French ministries of health and jus-
tice decided to make prevalence estimates for mental dis-
orders in French prisons. A cross sectional study of 1000
prisoners selected from 22 prisons using a stratified ran-
dom sample strategy was conducted between September
2003 and July 2004.
Selection of prisons
There are three types of prison in France. "Maisons
d'Arrêt" are intended for remand prisoners or prisoners
with short sentences. "Prisons centrales" are for prisoners
with long sentences entailing maximum security. "Centres
de détention" are intermediate.
Selection of prisoners
A number of 1000 prisoners to recruit was calculated to
detect a pathology with a prevalence of 20% with a 95%
confidence interval of ± 2.5%. 998 subjects were indeed
sampled from these prisons between September 2003 and
July 2004: 100 women, 100 men from France's overseas
départements and 798 men from metropolitan France.
This number of subject was chosen 1) to allow a good fea-
sibility according to the budget of the study 2) to avoid a
design effect in the calculation of statistical power. The
998 prisoners were selected using a stratified random
sampling strategy. 23 prisons centres were randomised
among the 188 prisons existing in France at the time of
the study: 13 maisons d'arrêt (two having a capacity of
more than a 1000 prisoners, 3 between 400 and 1000, 4
between 100 and 400, and 4 less than 100), 5 centres de
detention (2 national and 3 regional centers), 2 prisons
centrales, one male centre in a French overseas départe-
ment and two prisons for women were chosen at random
(for women, no prison centrale was selected). Prisoners
were then selected at random in the population of each
selected prison. The percent of prisoners selected in each
prison was between 1.4% (for "maison d'arret") and 5.1%
(for "maison centrale") according to the real size of each
center, which correspond to the recruitment of 50 prison-
ers by center (except for the 4 centers of less than 400 pris-
oners were the number was 37 prisoners and 13 prisoners
for the 4 centers of less than 100)."
After fully describing the study to the subjects, written
informed consent was obtained.
Data collection, diagnosis procedure
Each prisoner was interviewed for approximately 2 hours
by a group of 2 clinicians (clinical psychologist or psychi-
atrist). At least one of these clinicians had to be a senior
psychiatrist; neither could belong to the prison medical
team.
Diagnoses were then collected according to a semi-struc-
tured procedure validated in a previous study [44]: one of
the clinicians used a structured clinical interview generat-
ing DSM IV diagnoses (MINI plus v 5.0 [45]); the second,
more experienced, completed the procedure with an open
clinical interview, intended to be more clinically relevant.
The interview continued with the clinician-version of Clo-
ninger's Temperament and Character Inventory (TCI) [46]
and various questions on socio-demographics, legal sta-
tus, previous treatment and history of trauma. At the end
of the interview, each clinician independently summa-
rized his/her list of diagnoses [47]; then they met and
agreed on list of diagnoses.
All interviewers had specific training in the methodology
and the instruments used in this study.
Sample validation
57% of prisoners were available at the time of interview
and accepted. Collaboration with prisoners was good to
very good 88% of the time and average 10% of the time.
There was no problem speaking/understanding French in
85% of cases.
Inter-rater agreement on diagnosis assessment for the
total sample was estimated. All the values of Cohen's
Kappa corresponded to "good" (> 0.6) or "excellent" (>
0.8) agreement [48], with very high scores for alcohol
dependence (0.91), and drug dependence (0.95). OnlySubstance Abuse Treatment, Prevention, and Policy 2007, 2:1 http://www.substanceabusepolicy.com/content/2/1/1
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hypomania/mania had moderate inter-rater agreement
(0.53).
DSM-IV psychiatric diagnoses
The 23 possible diagnoses were grouped into 9 diagnoses,
recorded as current (C) and/or lifetime (LT): mood disor-
ders (major depressive disorder (C/LT), dysthymia (C),
mania/hypomania (C/LT), bipolar disorder (LT), psy-
chotic symptoms limited to depressive/manic episode (C/
LT)), anxiety disorders (panic disorder (C/LT), agorapho-
bia (LT), generalized anxiety (LT), social phobia (LT),
obsessive-compulsive disorder (LT), post-traumatic stress
(LT)), psychotic syndrome (schizophrenia (CT/LT), brief
psychotic disorder (C/LT), schizophreniform disorder(C/
LT), schizoaffective disorder (C/LT), delusional disorder
(C/LT), psychotic disorder not otherwise specified (C/LT)
and antisocial personality (LT). Prisoners with either a
drug abuse or dependence disorder consensual diagnosis
in the last 12 months were labelled DAD (Drug abuse or
dependence), while those with either a alcohol abuse or
dependence disorder in the last 12 months were libelled
AAD (alcohol use or dependence). Those two variables are
thus the aggregation of both prisoners with an abuse or
dependence disorder in the last 12 months, respectively
for alcohol and drug. They were design to cover a broad
range of severity of substance use, in term of regular use or
adverse consequences.
Ethics
This study was considered as having a direct individual
benefit according to CCPPRB (French ethical committee)
decision since a procedure to signal prisoners to the
prison medical team was provided for in two cases: in case
of psychiatric emergency (particularly high risk of sui-
cide), with or without the permission of the patient, and
in cases where psychiatric disorders were deemed serious,
only with the permission of the prisoners. A form was
designed for this procedure. About 22% of prisoners were
signalled to the prison medical team (with the agreement
of the prisoners; patients already followed for psychiatric
reasons were not signalled).
Statistical analysis
Statistical analyses were performed with SAS 8.6, except
the multiple imputation of missing data, which was per-
formed with the Gibbs sampler package of R 2.0.1 [49].
Two tailed T-test and Pearson CHI-2 test were used for the
univariate analysis. Multiple logistic regressions using a
stepwise selection process were used to analyse the factors
associated with 1) drug abuse/dependence disorder in the
past 12 months 2) alcohol abuse/dependence in the past
12 months. The fit of the model was good and conver-
gence criteria were met.
A multiple imputation procedure was used to take
account of missing data. They were no missing data for
consensual diagnosis. Only the following variables had
more than 2% of missing data: type of crime committed
(5.6%), work in prison (3.1%), length of sentence
(27.25%), and TCI variables (11.12%). n 2% of missing
data except for type of crime committed (5.6%), work in
prison (3.1%), length of sentence (27.25%), and TCI var-
iables (11.12%). No major differences were observed
between the multiple logistic regressions with or without
imputations.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
M.L participated to the design, the statistic and the draft of
this paper
B.F participated to the design and the statistic of this paper
I.G participated to the design and the draft of this paper
X.N participated to secondary statistical analysis
L.M criticaly revised this paper and gave expert opinion
M.R criticaly revised this paper and gave expert opinion
Acknowledgements
French Ministery of Health. Departement of justice and French administra-
tion penitentiare.
References
1. Mason D, Birmingham L, Grubin D: Substance use in remand
prisoners: a consecutive case study.  Bmj 1997, 315:18-21.
2. Fiscella K, Pless N, Meldrum S, Fiscella P: Benign neglect or
neglected abuse: drug and alcohol withdrawal in U.S. jails.  J
Law Med Ethics 2004, 32:129-136.
3. Obradovic I: Addiction en milieu carcéral. Enquête sur la prise
en charge sanitaire et sociale des personnes détenues
présentant une dépendance aux produits licites ou illicites
ou ayant une consommation abusive en 2003.  Edited by: toxi-
comanies OFDTOF. Paris, France, ; 2004. 
4. Modesto-Lowe V, Fritz EM: Recognition and treatment of alco-
hol use disorders in US jails.  Psychiatr Serv 2003, 54:1413-1414.
5. EMCDDA: Annual report 2004: the state of the drugs prob-
lem in the European Union and Norway.  Edited by: community
EMCDDAOE. Luxembourg, ; 2004. 
6. Mouquet MC: La santé des personnes entrées en prison en
2003.  In Etudes et Résultats Volume 386. Edited by: Direction de la
recherche des études de l'évaluation et des statistiques. Ministère de
l'Emploi . Paris, ; 2005. 
7. Duhamel A, Renard JM, Nuttens MC, Devos P, Beuscart R, Archer E:
Social and health status of arrivals in a French prison: a con-
secutive case study from 1989 to 1995.  Rev Epidemiol Sante Pub-
lique 2001, 49:229-238.
8. Brooke D, Taylor C, Gunn J, Maden A: Point prevalence of men-
tal disorder in unconvicted male prisoners in England and
Wales.  Bmj 1996, 313:1524-1527.
9. Andersen HS: Mental health in Prison Popualtions. A review
with special emphasis on a study of danish prisoners on
remand.  Acta Psychiatr Scand 2004, 110:.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Substance Abuse Treatment, Prevention, and Policy 2007, 2:1 http://www.substanceabusepolicy.com/content/2/1/1
Page 10 of 10
(page number not for citation purposes)
10. Brinded PM, Simpson AI, Laidlaw TM, Fairley N, Malcolm F: Preva-
lence of psychiatric disorders in New Zealand prisons: a
national study.  Aust N Z J Psychiatry 2001, 35:166-173.
11. Bushnell JA, Bakker LW: Substance use disorders among men in
prison: a New Zealand study.  Aust N Z J Psychiatry 1997,
31:577-581.
12. Peters RH, Greenbaund PE, Edens JF, Carter CR, Ortiz MM: Preva-
lence of DSMIV substance abuse and dependance among
prison inmates.  Am J Drug Alcohol Abuse 1998, 24:573-587.
13. Lo CC, Stephen RC: Drugs and prisonners : treatment needs
on entering prison.  Am J Drug Alcohol Abuse 2000, 26:229-245.
14. Singleton N, Farrel M, Meltzer H: Substance misuse among pris-
onners in England and Wales.  Edited by: Statistic ON. London, ;
1999. 
15. Brugha T, Singleton N, Meltzer H, Bebbington P, Farrell M, Jenkins R,
Coid J, Fryers T, Melzer D, Lewis G: Psychosis in the community
and in prisons: a report from the British National Survey of
psychiatric morbidity.  Am J Psychiatry 2005, 162:774-780.
16. Farrell M, Boys A, Bebbington P, Brugha T, Coid J, Jenkins R, Lewis G,
Meltzer H, Marsden J, Singleton N, Taylor C: Psychosis and drug
dependence: results from a national survey of prisoners.  Br J
Psychiatry 2002, 181:393-398.
17. Boys A, Farrell M, Bebbington P, Brugha T, Coid J, Jenkins R, Lewis G,
Marsden J, Meltzer H, Singleton N, Taylor C: Drug use and initia-
tion in prison: results from a national prison survey in Eng-
land and Wales.  Addiction 2002, 97:1551-1560.
18. Korte T, Pykalainen J, Seppala T: Drug abuse of Finnish male pris-
oners in 1995.  Forensic Sci Int 1998, 97:171-183.
19. Fishbein DH, Reuland M: Psychological correlates of frequency
and type of drug use among jail inmates.  Addict Behav 1994,
19:583-598.
20. Johnson RJ, Ross MW, Taylor WC, Williams ML, Carvajal RI, Peters
RJ: A history of drug use and childhood sexual abuse among
incarcerated males in a county jail.  Subst Use Misuse 2005,
40:211-229.
21. Brooke D, Taylor C, Gunn J, Maden A: Substance misuse as a
marker of vulnerability among male prisoners on remand.  Br
J Psychiatry 2000, 177:248-251.
22. Fotiadou M, Livaditis M, Manou I, Kaniotou E, Samakouri M, Tzavaras
N, Xenitidis K: Self-reported substance misuse in Greek male
prisoners.  Eur Addict Res 2004, 10:56-60.
23. Chen CC, Tsai SY, Su LW, Yang TW, Tsai CJ, Hwu HG: Psychiatric
co-morbidity among male heroin addicts: differences
between hospital and incarcerated subjects in Taiwan.  Addic-
tion 1999, 94:825-832.
24. Fazel S, Danesh J: Serious mental disorder in 23000 prisoners:
a systematic review of 62 surveys.  Lancet 2002, 359:545-550.
25. Prieto N, Faure P: [The mental health of new prisoners or of
those monitored in French prisons with "services medicops-
ychologiques regionaux" (SMPR, Regional Medical and Psy-
chological Departments).].  Encephale 2004, 30:525-531.
26. Reitox R: Report to the EMCDDA : France drug situation
2003.  Paris, Observatoire Francais des drogues et toxicomanies;
2004. 
27. Volkow ND: The reality of comorbidity: Depression and drug
abuse.  Biol Psychiatry 2004, 57:640-646.
28. Degenhardt L, Hall W: Is cannabis use a contributory cause of
psychosis?  Can J Psychiatry 2006, 51:556-565.
29. Degenhardt L, Hall W, Lynskey M: Exploring the association
between cannabis use and depression.  Addiction 2003,
98:1493-1504.
30. Zuckerman M: sensation seeking : the initial motive for drug
abuse.  In Etiological aspects of alcohol and drug abuse Edited by: Tho-
mas . Springfield, ; 1983. 
31. Cloninger CR: A systematic method for clinical and descrip-
tion and classification of personnality variant.  Arch Gen Psychi-
atry 1987, 44:584-587.
32. Le Bon O, Basiaux P, Streel E, Tecco J, Hanak C, Hansenne M, Ans-
seau M, Pelc I, Verbanck P, Dupont S: Personnality profil an drug
of choice : a multivariate anlaysis using cloninger's TCI on
heroin addicts, alcoholics, and a random population group.
Drug Alcohol Depend 2004:175-182.
33. Khan AA, Jacobson KC, Gardner CO, Prescott CA, Kendler KS: Per-
sonality and comorbidity of common psychiatric disorders.
British Journal of Psychiatry 2005:190-196.
34. De Wit H, Bodker B: Personality and drug preferences in nor-
mal volunteers.  Int J Addict 1994, 29:1617-1630.
35. Conway KP, Swendsen JD, Rounsaville BJ, Merikangas KR: Person-
nality, drug of choice, and comorbid psychopathology among
substance users.  Drug Alcohol Depend 2002, 65:225-234.
36. Lejoyeux M: Alcohol dependence, temper and peronality.  Med
Sci (Paris) 2004, 20:1140-1144.
37. Cloninger CR, Bohman M, Siqvardsson S: Inheritance of alcohol
abuse: cross-fostering analysis of adopted men.  Arch Gen Psy-
chiatry 1981:861-868.
38. Wang MQ, Matthew RF, Bellamy N, James S: A structural model
of the substance use pathway among minority youth.  AM J
Healh Behav 2005, 29:531-541.
39. Greydamus DE, Patel DR: The adolescence and Substance
Abuse : Current concepts.  Disease-a-month 2005, 51:392-431.
40. Timmerman IG, Emmelkamp PM: The relationship between
attachment styles and cluster B personnality disorders in
prisoners and forensic inpatients.  Int J Law Psychiatry 2006,
29:48-56.
41. Alati R, Najman JM, Kinner SA, Mamun AA, Williams GM, O'Callaghan
M, Bor W: Early prectors of adult drinking : a birth cohort
study.  Am J Epidemiol 2005, 162:1098-1107.
42. Beyers JM, Tombourou JW, Catalano RF, Arthur MW, Hawkins JD: a
cross-national comparison of risk and protective factros for
adolescent substance use : the United States and Australia.
J Adolesc Health 2004, 35:3-16.
43. Ouimette P, Read J, Brown PJ: Consistency of retrospective
reports of DSM-IV criterion A traumatic stressors among
substance use disorder patients.  J Trauma Stress 2005, 18:43-51.
44. Loze JY, Falissard B, Limosin F, Recasens C, Horreard AS, Rouillon F:
Validation of a new diagnostic procedure for DSM IV axis I
disorders.  Int J Methods Psychiatr Res 2002, 11:134-141.
45. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller
E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neu-
ropsychiatric Interview (M.I.N.I.): the development and vali-
dation of a structured diagnostic psychiatric interview for
DSM-IV and ICD-10.  J Clin Psychiatry 1998, 59 Suppl 20:22-33;quiz
34-57.
46. Cloninger CR: A practical way to diagnosis personality disor-
der: a proposal.  J Personal Disord 2000, 14:99-108.
47. Guy W: Clinical Global Impression.  ECDEU Assessment Manual for
Psychopharmacology, revised National Institute of Mental Health, Rockville,
MD 1976.
48. Cicchetti DV, Sparrow SS: Developing criteria for establishing
the interrater reliability of specific item in a given inventory:
Applications to the assessment of adaptive behavior.  Am J
Ment Defic 1981, 86:127-137.
49. R Development Core Team: R: A language and environment for
statistical computing.   [http://www.R-project.org].